Schisandrin B preparation

Details Schisandrin B preparation Schisandrin B preparation

2007-10-02

2007-10-02

Hoffman, Susan Coe (Department: 1655)

Drug, bio-affecting and body treating compositions

Plant material or plant extract of undetermined constitution...

Reexamination Certificate

active

11188021

ABSTRACT:
The present invention provides a preparation for treatment or prevention of a condition in a patient, said preparation comprising Schisandrin B. The concentration of Schisandrin B in the preparation may be between about 0.01 and about 0.1%, or it may be between about 20 and about 40% w/w or w/v. The preparation may additionally comprise one or more components selected from the group consisting of herbal extracts, fluids, solvents, antioxidants, preservatives, electrolytes, salts and pH control agents.

REFERENCES:
patent: 4684628 (1987-08-01), Liu
patent: 5484595 (1996-01-01), Ikeya et al.
patent: 6261565 (2001-07-01), Empie et al.
patent: 6596321 (2003-07-01), Yan et al.
patent: 6605305 (2003-08-01), Zhao
patent: 2002/0127189 (2002-09-01), Myers et al.
patent: 2005/0119337 (2005-06-01), Hu
patent: 1415318 (2003-05-01), None
patent: 2186572 (1987-08-01), None
patent: WO 00/74697 (2000-12-01), None
Ko et al. (Phytotherapy Research (1996), vol. 10, pp. 450-452).
Panossian et al. (Phytomedicine (1999), vol. 6, No. 1, pp. 17-26).
http://www.amazon.com/Herbal-Traditional-Medicine-Molecular-Oxidative/dp/0824754360—accessed Mar. 22, 2007.
Kam-Ming Ko et al., Pharmaceutical Biology 2002, vol. 40, No. 4, pp. 298-301, Protection against Carbon Tetrachloride Liver Toxicity by Enantiomers of Schisandrin B Associate.
Kam-Ming Ko, Shengmai San: Traditional Herbal Medicines for Modern Times, vol. 1 2002.
Ji, Yuxia et al., “Preparation and quality evaluation ofSchisandra chinensisparenteral emulsion′” Zhongguo Yiyuan Yaoxue Zazhi, 2004, 24(11): 713-714, China.
Du, Yingfeng et al. “Determination of deoxyschizandrin and schizandrin B inSchisandra chinensisand Weiganfutai tablets by RP-HPLC” Zhongcaoyao, 2004, 35 (5): 519-521, China.
He, Yanping et al. “Quantitative analysis of γ-schizandrin in Manganbao granules, A complex prescription of Chinese medicine”. Zhongguo Zhongyao Zazhi, 1995, 20(9): 541-2, China.
Cui, Langui et al. “Determination of deoxyschizandrin and schisandrin B in Gengnianan tablets by HPLC”, Zhongcaoyao, 2001, 32(5): 409-411, China.
Zhong, Zhaoqing et al. “HPLC determination of schizandrin B in Livoprotect tablets.”. Zhongcaoyao, 1996, 27(4):215-216, China.
Liu, Qunfeng et al. “Simultaneous determination of schizandrin A and B in Gandeining pill by HPLC”, Zhongguo Zhongyao Zazhi, 2000, 25(3): 157-158, China.
Tian, Gengcun et al. “The preparation, pharmacology and clinical application of Shengmaisan′” Chinese Traditional Patent Medicine, 2000; 22(2): 162-165.
Ko, RKM, and Mak, DHF: “Schisandrin B and other Dibenzocyclooctadiene lignans. In: Herbal and Traditional Medicine: Molecular Aspects of Health.” Packer L, Halliwell B, Ong CN, editors. Marcel Dekker: New York, Basel, Hong Kong, 2004, pp. 289-314.

Affiliated with

Also associated with

Rating

Schisandrin B preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Schisandrin B preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Schisandrin B preparation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3829127